$NTRR Targets New Disposable Inhaler Technology Poised to Revolutionize Nutraceuticals Market

In its quest to build a portfolio of wellness-related technology assets ripe for commercialization,Neutra Corp. (NTRR) announced today that it plans to capitalize on the game-changing potential of a new innovation in a global nutraceuticals market forecast to reach $424 billion by 2017.

Disposable inhaler technology could be poised to become a new and better industry standard for a wide variety of supplements and nutraceuticals, and NTRR wants in on the ground floor, says CEO Chris Brown.

“This is a cutting-edge innovation that could soon enable the use of inhaled nutraceuticals from glucosamine to cannabis,” Brown said. “It could completely change the way we deliver immune boosters, pain relievers, vitamins and more. There any many potential avenues for commercialization available, and we are examining all of them very closely.”

Disposable inhalers, which can be packed with nutraceuticals pre-loaded, can be used for pulmonary delivery in a wide variety of uses with no smoke and no smell. The technology is a natural fit for NTRR, a company with extensive experience with inhalation devices.

By marketing single-use inhalation technologies to health-conscious consumers in new industries, NTRR hopes to significantly expand its earnings potential.

About Neutra Corp.

Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (GWPRF), INSYS Therapeutics, Inc. (INSY) and ENDEXX Corp. (EDXC), delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit www.neutracorp.com.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.